New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
A Technical Consultation on WHO Prequalification Requirements for Mycobacterium tuberculosis complex (MTBC) NAT assays was held 22-24 November.
An online information session about the Prequalification of glucose monitoring devices was held for manufacturers on Friday 5 November.
The 9th annual collaborative registration procedure (CRP) meeting for National Regulatory Authorities (NRAs) was held 13 - 17 December.
The In Vitro Diagnostics Assessment Team continues its focus on assessing IVDs for detection of SARS-CoV-2 under the WHO Emergency Use Listing assessment procedure.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Nirmatrelvir 150mg tablets + ritonavir 100mg tablets invited for COVID-19.
The WHO list of prequalified in vitro diagnostic products has been updated.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
See full report:
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Ritonavir (WHOAPI-398) manufactured by Laurus Labs Limited has been prequalified by the WHO Prequalification Unit - Medicines Team (PQT/MED) under its API prequalification procedure.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
Addition under section:
Baricitinib 2mg tablets and sotrovimab solution for infusion, 500 mg/8 mL (62.5 mg/mL) single use vial, invited for COVID-19.
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
The World Health Organization (WHO), together with the United Nation’s Children Fund (UNICEF) and the United Nations Population Fund (UNFPA), will hold a three-day virtual meeting on 8-10 March 202
Contractual Arrangement: External consultant
Contract Duration: 8 months
Job Posting: Nov 15, 2021, 7:46:07 PM
The WHO list of prequalified in vitro diagnostic products has been updated.